AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 189 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $95,939 | -31.1% | 16,802 | -39.6% | 0.01% | -22.2% |
Q1 2024 | $139,288 | -6.7% | 27,802 | +67.4% | 0.02% | -37.9% |
Q4 2023 | $149,351 | +423.3% | 16,613 | +352.3% | 0.03% | +262.5% |
Q3 2023 | $28,539 | +57.2% | 3,673 | +95.9% | 0.01% | +33.3% |
Q2 2023 | $18,150 | -14.3% | 1,875 | -3.0% | 0.01% | -14.3% |
Q1 2023 | $21,175 | +239.5% | 1,932 | +33.8% | 0.01% | +133.3% |
Q4 2022 | $6,238 | -37.6% | 1,444 | +8.7% | 0.00% | -25.0% |
Q3 2022 | $10,000 | – | 1,328 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |